Mushrooms may be the savior of depression patients
Mushrooms may be the savior of depression patients May 25, 2016 Source: Singularity Network According to estimates by the World Health Organization, at least 350 million people worldwide suffer from depression. They have long been plagued by sorrow, inferiority, insomnia, and anorexia. They can't find fun and meaning in life. This state may accompany them for decades, even for a lifetime. Fortunately, ordinary antidepressants and cognitive behavioral treatments have a certain effect on most people, which partially relieves the suffering of patients. However, about 20% of patients show "resistance" to traditional treatments, and they suffer from Called refractory depression. More than 70 million patients can only struggle in depression. I still remember that last month it seemed that some people said that day lily can treat depression. As for not doing it, I don't know. Anyway, I didn't find the endorsement of the literature. On Tuesday, David Nutt's research team from Imperial College London found that a Psilocybe mushroom could be a cure for depression. Their research results are published in the "Lancet Psychiatry" of the Lancet (1). David Nutt (a "fantasy" mushroom model on the balcony) The study, led by Robin Carhart-Harris of Imperial College London, found that Psilocybin, a psychedelic ingredient in mushrooms, can alleviate refractory depression patients. Disease. I don't know if this news can sweep away the haze on the faces of a large number of depressed patients, so that they are full of expectations for a better life in the future. Art photo of "Fantasy" mushroom (MARTIN BOND) According to the literature, the "fantasy" mushroom has been used as a cure for diseases for thousands of years. But its modern pharmacy significance was not discovered until the late 1950s (2). Roland Griffiths, a researcher at Johns Hopkins University, discovered in 2006 that after taking the right amount of "fantasy" mushrooms, it would make life feel meaningful (3). Since then, Griffiths has been convinced that the "fantasy" mushroom will shine in the treatment of human mental illness. The research results of the predecessors have led some researchers to see the medicinal value of the "fantasy" mushroom. In 2011, Charles Grob of the University of California conducted a cephalosporin test on 12 patients with advanced anxiety who were emotionally anxious. He found that cancer patients taking cephalosporin apparently felt relieved of depression and anxiety (4). The Carhart-Harris team at Imperial College London is also one of them. Carhart-Harris discovered that there was no clinical trial of cephalosporin in the treatment of depression after learning about the progress of the "noring" mushroom. However, there have been some sporadic studies showing that there is a high potential for the treatment of depression. So, the Carhart-Harris team organized this clinical study. "Fantasy" mushroom life photo Carhart-Harris recruited 12 patients with refractory depression, 6 men and 6 women, who were afflicted with depression for an average of 18 years, including the longest period of depression for more than 30 years and the shortest for 8 years. They have received multiple (at least 2, up to 11) multiple methods (minimum 2, up to 8) treatment, including but not limited to selective serotonin reuptake inhibitors (SSRIs) and electroconvulsive therapy Etc., have not been alleviated. All 12 patients had a significant improvement in symptoms after one week of treatment. Three months later, five patients had different degrees of recurrence, two patients were better than before taking cephalosporin, and five patients had complete relief of depression. In the face of this research, Carhart-Harris said, "The performance of naked head grass is good. Indeed, after all, all patients are unresponsive to other treatments. The "noisy" mushroom's naked head grass has not only therapeutic effects, but also has few side effects caused by traditional treatments. What is even more surprising to the researchers is that the advantages of N. sylvestris are far more than that, Carhart-Harris said, "It is different from traditional treatment of depression, which requires a single dose of oxalochlorine to relieve the disease. effect. This is probably the most exciting place for patients. This is probably one of the main reasons why this preliminary research result can explode foreign media. Another thing that has to be mentioned is that the cephalosporin contained in the "Fantasy" mushroom has a strong hallucinogenic effect and has been classified by the British authorities as heroin and cocaine as a Class A illegal drug. This is the most serious category. According to Nutt, the clinical research process of cephalosporin is extremely difficult, from the application of the authorities to carry out clinical trials, to the first patient taking the drug, separated by 32 months. It takes only 6 months to know the clinical approval of his other illicit drug LSD (D-lysergic acid diethylamine, a strong semi-artifical hallucinogen). However, Carhart-Harris's research also has its flaws. For example, the sample studied was too small to have a placebo-controlled trial. It is said that this is a very serious defect, but considering the amount of oxalochlor in this study is extremely large, the extraction of stalk is not easy, and the recruitment of patients with refractory depression, so Carhart- Harris' research results are still of great value. At least, their research points to a new direction for the treatment of refractory depression. It is estimated that this is one of the main reasons why it can pass peer review. In short, it seems that the cephalosporin in the "fantasy" mushroom is extremely valuable for the treatment of depression. But more and more research is needed to confirm this conclusion. As a big cow to study the "fantasy" mushroom, David Nutt will definitely be looking for the raw grass. The relevant departments of drug approval may have to consider the process of optimizing the approval of such drugs after the clinical trial, and formulate relevant drug regulatory policies. Friendly reminder: This research is still in the experimental stage. Please don't ask friends for the Taobao link, and don't just pick the mushrooms on the cow dung. alpha arbutin .kojic acid powder .nmn powder.coenzyme q10 powder. glutathione powder .apigenin powder. aloe vera gel freeze dried powder etc Cosmetic Ingredients,Strawberry Powder,Kojic Acid Powder,Glutathione Powder Youth Biotech CO,. Ltd. , https://www.youtherb.com